These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Management of Crohn's Disease After Surgical Resection. Singh S; Nguyen GC Gastroenterol Clin North Am; 2017 Sep; 46(3):563-575. PubMed ID: 28838415 [TBL] [Abstract][Full Text] [Related]
30. Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases. van Dullemen HM; de Jong E; Slors F; Tytgat GN; van Deventer SJ Dis Colon Rectum; 1998 Jan; 41(1):98-102. PubMed ID: 9510318 [TBL] [Abstract][Full Text] [Related]
31. Inducing remission of ulcerative colitis: are clinicians better equipped than ever? Armuzzi A; Felice C Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):95-7. PubMed ID: 23363258 [No Abstract] [Full Text] [Related]
32. Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease. Hommes DW; van Dullemen HM; Levi M; van der Ende A; Woody J; Tytgat GN; van Deventer SJ Haemostasis; 1997; 27(6):269-77. PubMed ID: 9731107 [TBL] [Abstract][Full Text] [Related]
33. Antibody to tumor necrosis factor in the treatment of Crohn's disease. Stricker T; Braegger CP J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):369-70. PubMed ID: 9740217 [No Abstract] [Full Text] [Related]
34. Anti-TNF antibody treatment of Crohn's disease. van Deventer SJ Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987 [No Abstract] [Full Text] [Related]
35. Monoclonal antibody approved for treatment of Crohn's disease. Freeman TR; Piascik P J Am Pharm Assoc (Wash); 1998; 38(6):770-2. PubMed ID: 9861797 [No Abstract] [Full Text] [Related]
36. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Mudter J; Neurath MF Gut; 2007 Feb; 56(2):293-303. PubMed ID: 16956919 [No Abstract] [Full Text] [Related]
37. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Guslandi M; Mezzi G; Sorghi M; Testoni PA Dig Dis Sci; 2000 Jul; 45(7):1462-4. PubMed ID: 10961730 [TBL] [Abstract][Full Text] [Related]
38. Medical options for treating Crohn's disease in adults: focus on antitumor necrosis factor-alpha chimeric monoclonal antibody. Wall GC; Heyneman C; Pfanner TP Pharmacotherapy; 1999 Oct; 19(10):1138-52. PubMed ID: 10512063 [TBL] [Abstract][Full Text] [Related]
39. Mesalamine in the treatment of active Crohn's disease. Dignass A; Marteau P Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152 [No Abstract] [Full Text] [Related]